Učitavanje...

Prevalence of plasma autoantibody against cancer testis antigen NY-ESO-1 in HTLV-1 infected individuals with different clinical status

BACKGROUND: Detection of specific immune responses against cancer/testis antigen NY-ESO-1 was recently reported in patients with adult T-cell leukemia/lymphoma (ATL) and human T-cell leukemia virus type 1 (HTLV-1)-infected asymptomatic carriers (ACs). However, the relationship of the responses with...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:Virol J
Glavni autori: Shiohama, Yasuo, Naito, Tadasuke, Matsuzaki, Toshio, Tanaka, Reiko, Tomoyose, Takeaki, Takashima, Hiroshi, Fukushima, Takuya, Tanaka, Yuetsu, Saito, Mineki
Format: Artigo
Jezik:Inglês
Izdano: BioMed Central 2017
Teme:
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC5512893/
https://ncbi.nlm.nih.gov/pubmed/28716148
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12985-017-0802-9
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!